Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Oct;23(10):1703-1706.
doi: 10.3201/eid2310.170106.

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015

Takaaki Tanaka, Tomohiro Oishi, Ippei Miyata, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Yoko Fukuda, Aki Saito, Eisuke Kondo, Hideto Teranishi, Yuhei Tanaka, Tokio Wakabayashi, Hiroto Akaike, Satoko Ogita, Naoki Ohno, Takashi Nakano, Kihei Terada, Kazunobu Ouchi
Multicenter Study

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015

Takaaki Tanaka et al. Emerg Infect Dis. 2017 Oct.

Abstract

We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children in Japan has decreased.

Keywords: Japan; Mycoplasma pneumoniae; antimicrobial resistance; bacteria; children; drug resistance; macrolides; real-time PCR.

PubMed Disclaimer

Figures

Figure
Figure
Districts of origin for patients with Mycoplasma pneumoniae infection, Japan, 2008–2015: 1, Kyushu; 2, Chugoku-Shikoku; 3, Kinki; 4, Kanto-Chubu; 5, Tohoku-Hokkaido.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother. 2013;57:4046–9. 10.1128/AAC.00663-13 - DOI - PMC - PubMed
    1. Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521–3. 10.1128/AAC.02060-12 - DOI - PMC - PubMed
    1. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M; Atypical Pathogen Study Group. Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur J Clin Microbiol Infect Dis. 2011;30:439–46. 10.1007/s10096-010-1107-8 - DOI - PubMed
    1. Joint Committee of Japanese Society of Pediatric Infectious Disease and Japanese Society of Pediatric Pulmonology. Pneumonia. In: Ouchi K, Kurosaki T, Okada K, editors. Guidelines for management of respiratory infectious diseases in children in Japan 2011 [in Japanese]. Tokyo: Kyowa Kikaku Ltd.; 2011. p. 44
    1. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al.; Atypical Pathogen Study Group. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis. 2012;12:126. 10.1186/1471-2334-12-126 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources